The UAMS Myeloma Institute is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia.  Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Institute is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.

We are committed to

  • Accelerating curative therapies for multiple myeloma and related diseases through an integrated program of innovative research and high-quality, comprehensive patient care
  • Customizing care based on each patient’s genetic profile and risk factors for truly personalized treatment
  • Pushing the envelope of understanding and discovery to unravel the biology of multiple myeloma and maximize cure

Latest News

View Myeloma News Archive